Skip to content
GLP-1 Desk
Menu
Dispatch #25Editorial

HydraMed

Mid-market injectable pricing available in just eleven states, without third-party verification.

Visit HydraMedEditorial — no commercial relationship.
Semaglutide
$179/mo
Tirzepatide
$319/mo
Coverage
CO, FL, TX, TN, GA, AZ, IL, NV, VA, MD, WY
Brand-name
Compounded only

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency80/100
State access64/100
Molecule range80/100
Onboarding speed80/100
Support responsiveness78/100
Licensing & trust72/100

What the Desk likes

  • Both molecules available
  • Mid-market semaglutide pricing

Where points come off

  • Only eleven states served
  • No LegitScript verification
  • Tirzepatide priced above value leaders

The Desk's briefing — C

Best for: Patients in a covered state who want a simple injectable program and don't need brand or oral options.

HydraMed ranks #25 of 25 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect HydraMed's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on HydraMed's site. Not medical advice; see our disclosure.

← Back to The Desk